Literature DB >> 8060090

Quality assessment of urinary organic acid analysis.

J R Bonham1, M Downing, R J Pollitt, N J Manning, K H Carpenter, S E Olpin, J C Allen, E Worthy.   

Abstract

The number of known inherited metabolic disorders resulting in an organic aciduria has increased steadily over the past two decades. Prompt and reliable detection is both clinically and technically demanding but is essential if appropriate treatment is to be undertaken. This is the first study of laboratory performance in the detection of these disorders to be undertaken in the UK. Some conditions were accurately identified by most laboratories: for example for maple syrup urine disease, 12 of 14 laboratories provided an appropriate response and medium chain acyl-CoA dehydrogenase deficiency was correctly identified by 15 of 17 laboratories. However, accuracy of detection was poorer for other conditions: for example, only eight of 17 laboratories detected tyrosinaemia type 1 and nine of 18 laboratories detected 4-hydroxybutyric aciduria. The strongest correlation with good performance was obtained by comparison with the extent of peak identification: r = 0.62, P = 0.002. The need for regular attendance at scientific symposia was also supported by a weaker positive correlation with the average score achieved, P = 0.08. Evidence also suggested that some of the laboratories with a low workload performed less well. No significant difference in performance could be demonstrated between the 17 laboratories who used gas chromatography-mass spectrometry and the six participants who used gas chromatography alone.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060090     DOI: 10.1177/000456329403100203

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis.

Authors:  M Downing; J C Allen; J R Bonham; R G Edwards; N J Manning; S E Olpin; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  External quality assurance programme for enzymatic analysis of lysosomal storage diseases: a pilot study.

Authors:  G J G Ruijter; M Boer; C W Weykamp; R de Vries; I van den Berg; J Janssens-Puister; K Niezen-Koning; R A Wevers; B J H M Poorthuis; O P van Diggelen
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Succinic semialdehyde dehydrogenase deficiency: low excretion of metabolites in a neonate.

Authors:  J J Pitt; R Hawkins; M Cleary; M Eggington; D R Thorburn; L Warwick
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

4.  Qualitative urinary organic acid analysis: methodological approaches and performance.

Authors:  V Peters; S F Garbade; C D Langhans; G F Hoffmann; R J Pollitt; M Downing; J R Bonham
Journal:  J Inherit Metab Dis       Date:  2008-11-07       Impact factor: 4.982

5.  Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.

Authors:  I Knerr; P L Pearl; T Bottiglieri; O Carter Snead; C Jakobs; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

6.  Qualitative urinary organic acid analysis: 10 years of quality assurance.

Authors:  Verena Peters; James R Bonham; Georg F Hoffmann; Camilla Scott; Claus-Dieter Langhans
Journal:  J Inherit Metab Dis       Date:  2016-05-04       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.